Cantor Fitzgerald Reiterates Exagen (XGN) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 22, 2023, Cantor Fitzgerald reiterated coverage of Exagen (NASDAQ:XGN) with a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2159357134-761fa1c2bc4b48cb890450528133ba86.jpg "<div>A Trade Loophole Is Closing. Here's What That Means for Your Online Shopping Costs</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-13181780681-2502efd7b00e410ca9e987334296eb92.jpg "<div>American Express's Main Competition</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2151268305-a63e7af07f6d48c1bf11b7959f62fb20.jpg "How Does Additional Equity Financing Affect Existing Shareholders?")
:max_bytes(150000):strip_icc():format(jpeg)/senior-manager-talks-to-the-employee-of-the-company-1026061082-5c94e85bc9e77c00015f69bc.jpg "<div>What Does a Merger or Acquisition Mean for the Target Company's Employees?</div>")
